Status:
COMPLETED
Natural Supplements for Unipolar Depression
Lead Sponsor:
Cambridge Health Alliance
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Unipolar Depression
Eligibility:
All Genders
18-64 years
Phase:
PHASE4
Brief Summary
This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression.
Detailed Description
The study is 6 weeks long, with 9 clinical visits. All visits will take place at our location in Massachusetts.
Eligibility Criteria
Inclusion
- DSM-IV diagnosis of a MDD or DDNOS; clinical indication for treatment of current depressive symptoms; HDS \> 18; women of reproductive potential must use an acceptable method of birth control
Exclusion
- Treatment with another psychotropic drug; history of mania or hypomania; history of bipolar illness in first-degree relatives; active homicidality; pregnant; trying to become pregnant, or nursing; unstable medical condition; current substance abuse in the past month; history of sulfa allergy
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00226356
Start Date
December 1 2004
End Date
September 17 2008
Last Update
April 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cambridge Health Alliance
Cambridge, Massachusetts, United States, 02139